Discovery of ecnoglutide – A novel, long-acting, cAMP-biased glucagon-like peptide-1 (GLP-1) analog
Wanjun Guo(Hangzhou Seventh Peoples Hospital), Hongbo Pan(National Federation of the Blind)
Cited by 43
Related Papers
Prevalence of depressive disorders and treatment in China: a cross-sectional epidemiological study
|The Lancet Psychiatry|2021|826